Gleevec holds potential as first drug to successfully treat neurofibromatosis

Researchers at the Indiana University School of Medicine report that the anti-cancer drug Gleevec holds out promise to become the first effective treatment for neurofibromatosis, a genetic disease that has resisted treatments until now.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news144597422.html">Gleevec holds potential as first drug to successfully treat neurofibromatosis</a></p> <p>Researchers at the Indiana University School of Medicine report that the anti-cancer drug Gleevec holds out promise to become the first effective treatment for neurofibromatosis, a genetic disease that has resisted treatments until now.</p>